CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]
Revenues	$ 56,913,534	$ 29,103,093
Cost of product revenue	40,400,544	25,441,046
Gross profit	16,512,990	3,662,047
OPERATING EXPENSES:
Research and development	855,351	624,111
Plasma center operating expenses	1,780,463	3,974,589
Amortization of intangible assets	178,838	178,838
Selling, general and administrative	14,511,656	13,699,575
Total operating expenses	17,326,308	18,477,113
LOSS FROM OPERATIONS	(813,318)	(14,815,066)
OTHER INCOME (EXPENSE):
Interest income	166,971	33,068
Interest expense	(6,115,484)	(3,389,038)
Loss on extinguishment of debt	0	(6,669,941)
Other expense	(26,984)	(166,880)
Other expense, net	(5,975,497)	(10,192,791)
NET LOSS	$ (6,788,815)	$ (25,007,857)
BASIC LOSS PER COMMON SHARE (in dollars per share)	$ (0.03)	$ (0.13)
DILUTED LOSS PER COMMON SHARE (in dollars per share)	$ (0.03)	$ (0.13)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic (in shares)	221,921,750	195,871,932
Diluted (in shares)	221,921,750	195,871,932